Ruti Aga and the Six-Year Ban: When a Fake Prescription Cost More Than the Banned Substance

The clinic on the prescription does not exist. The person who signed as "doctor" is a family member with no medical registration number. The paper pad was said to have come from a former workplace whose personnel records confirm that person never appeared on the staff list. Three details, stitched together, turned a two-year sanction into six. Ruti Aga, 32, the Ethiopian marathoner who won the 2026 Tokyo Marathon and finished runner-up at World Marathon Majors races three times, has been banned for six years, effective from 10 September. She tested positive for methylprednisolone — a synthetic glucocorticoid in class S9, prohibited in-competition only. The standard sanction for that class is two years. The other four years came from an entirely different charge: falsifying evidence during results management. Most headlines were built around the word "doping." The four years are the part worth reading. I have followed Aga since the 2026–2026 stretch when she moved into the lead group of Ethiopian women's marathon running. In Tokyo in 2026 she won a major with speed that was not her only weapon — she controlled the rhythm from around 25 kilometres, cut the final bend and finished with a safe margin. Three further runner-up finishes at World Marathon Majors races established her tier: a world-class road racer, the kind of athlete race organisers call first when they need a start list with weight. In March she won a half marathon in China. That is the single most important detail in the file, and the one the reporting handled most thinly. Chinese road races are not national championships. They are an appearance-fee market — organisers pay East African athletes to give a start list credibility, and the density of medical, logistical and paperwork scrutiny there is far thinner than at a major. Her time at that race was not disclosed in the source. The result is almost certainly annulled, along with the prize money. After the positive test, Aga offered an explanation: she was treating a knee injury. That is a medically coherent explanation. Glucocorticoids are widely used in joint injections. The problem lay elsewhere: no valid Therapeutic Use Exemption, and no declared route of administration. Then she falsified documents. Start with the point most easily misread: methylprednisolone is not an anabolic steroid. It is a synthetic glucocorticoid — an anti-inflammatory corticosteroid, class S9 on the WADA list, prohibited in-competition only. Several reports called it a "steroid," which lifts the severity of the case one notch above the chemistry. To a general reader, "steroid" evokes muscle gain and performance fraud; "corticosteroid" evokes a knee injection. The distinction is not pedantry. WADA classifies methylprednisolone as a Specified Substance — a category the rule-makers accept is more plausibly linked to inadvertent or therapeutic use. That is why the baseline sanction for the group is softer and the mitigation route wider. The substance half of this case, read through the logic of the Code, was the weak half. And yet the total was six years. The mechanism: two years for the presence of a prohibited substance, plus four years for tampering with results management, served consecutively rather than concurrently. The World Anti-Doping Code is explicit that multiple independent violations are served back to back. Put plainly, the four years came from the cover-up, not from the medication. And the cover-up is what makes this file worth dissecting. The Athletics Integrity Unit — World Athletics' independent integrity body — does not merely test. It cross-checks. It contacted the clinic named on the prescription directly, and the clinic confirmed the document was not theirs. It checked the registration number of the signing "doctor" and found none. It contacted the former employer from which the pad was said to have been taken, and that body confirmed the person had never worked there. Three verification layers, three failures, on one sheet of paper. Anyone who has handled medical paperwork should stop here: the AIU's document verification is now fast enough that a forged prescription has no chance of surviving more than a few weeks. If anyone in Aga's circle had read a single prior tampering decision, they would have known that. That they proceeded anyway, this crudely, says something structural about the support around East African athletes: no dedicated counsel, no compliance adviser, nobody in the room to sound an alarm. I have written before about "the invisible tacticians" — under-resourced athletes forced to invent their own systems. Here the invention was pointed in the wrong direction. A 32-year-old at the peak of both her competitive and commercial value faced a paperwork problem and solved it with forged paperwork, assembled by a relative with no expertise. That is not an international conspiracy. It is an administrative emergency handled by someone who did not know first aid. The economics are unambiguous. A six-year ban from 10 September returns her to eligibility at roughly 38. Women's marathon careers can stretch into the mid or late thirties, but six years away from elite competition is a gap nobody fills. Major invitations disappear. Appearance fees disappear. Sponsorship contracts face morality clauses. The Chinese half marathon prize is forfeited. In the road-racing economy an athlete is paid to appear; when she cannot appear, she stops being a revenue line. For Ethiopian athletics, the competitive damage is close to zero. The women's marathon pipeline is so deep that losing one place in the lead group is a struck-through line on an internal depth chart. The country does not lack people who can run under 2:20. It lacks file managers, lacks someone sitting beside the athlete when the letter from the AIU arrives. East Africa does not lack talent; it lacks record-keepers. I wrote that about women's football, and it holds here too, in an office where a forged prescription was typed out at night. One more gap in the source: neither the year of the March positive test nor the year of the 10 September provisional suspension is stated. In a case where every date determines eligibility, a missing year is a notable information hole — and a reminder that even the public files of integrity bodies have blind spots. It is also worth noting that after a tampering finding, retrospective review of stored samples or athlete biological passport data is a real possibility. Nothing suggests it is under way, but the mechanism exists. What most reports will not say: the doping half of this case could have ended at two years, or at no violation at all, with a properly obtained TUE. An intra-articular glucocorticoid injection for a knee injury is an ordinary medical indication. An exemption application filed a few weeks before the race, with a diagnosis, an indication and an independent treating physician, is a legal route and not a difficult one. That route closed not because the AIU is harsh, but because someone in Aga's circle decided forging was faster than filing. The counter-intuitive reading sits here: the public is consuming this as a moral tale about doping, when it is a story about administrative capacity. The heaviest penalty was not for taking a substance; it was for not knowing how to answer a letter. And the detail that made the story travel — the relative, the phantom clinic, the old pad — is the domestic detail, the one that gives the coverage an emotional register quite different from the usual male doping case, which tends to be told in the language of laboratories and cross-border schemes. I have no data proving that media treat female athletes differently from male athletes in doping cases. But I have spent more than twenty years reading sports journalism, and I know which stories get told in which register. A male athlete with a forged prescription is called an organised cheat. A female athlete with a forged prescription signed by a relative is called a tragedy. Both framings miss the point: she had a legal exit, and nobody showed her where it was. A six-year ban is the correct outcome under the rules, and that is exactly what makes it troubling. A system can only judge someone fairly when someone stands up to explain the rules to the person being judged. In East Africa, that layer barely exists. The first channel is always the hardest, but somebody has to hold the microphone. Here, the person who needed it was a short-term, hourly-rate lawyer sitting in an AIU meeting room with a 32-year-old athlete and an unsigned form. Had she had that person, we would not have this story to read.